These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2292054)

  • 1. Phase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinoma.
    Guimaraes JL; Ghosn M; Ostronoff M; Azab M; Theodore C; Droz JP
    Cancer Invest; 1990; 8(6):623-4. PubMed ID: 2292054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapy of metastatic renal cell carcinoma.
    Bukowski RM
    Cancer Invest; 1999; 17(6):460-1. PubMed ID: 10434957
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.
    Elias L; Blumenstein BA; Kish J; Flanigan RC; Wade JL; Lowe BA; Goodwin JW; Crawford ED
    Cancer; 1996 Sep; 78(5):1085-8. PubMed ID: 8780547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of untreated local advanced or metastatic renal cell carcinoma. Phase III, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in subjects with previously untreated, local advanced or metastatic renal cell carcinoma (CheckMate 214 - AN 36/15 of the AUO)].
    Rexer H
    Urologe A; 2015 Oct; 54(10):1443-5. PubMed ID: 26350358
    [No Abstract]   [Full Text] [Related]  

  • 5. [First-line therapy for German patients with metastatic kidney neoplasms in EORTC-Protocol 30012].
    Rexer H
    Urologe A; 2004 Aug; 43(8):992-3. PubMed ID: 15316609
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy in metastatic renal cell cancer.
    Lilleby W; Fosså SD
    World J Urol; 2005 Jul; 23(3):175-9. PubMed ID: 15726382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Combination Shows Strong Antitumor Activity in Metastatic Renal Cell Carcinoma.
    Kahl KL
    Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914201
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer.
    Gollob JA; Rathmell WK; Richmond TM; Marino CB; Miller EK; Grigson G; Watkins C; Gu L; Peterson BL; Wright JJ
    J Clin Oncol; 2007 Aug; 25(22):3288-95. PubMed ID: 17664476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma.
    Amato RJ; Morgan M; Rawat A
    Cancer; 2006 Apr; 106(7):1498-506. PubMed ID: 16475152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study.
    Ravaud A; Gomez-Roca C; Picat MQ; Digue L; Chevreau C; Gimbert A; Chauzit E; Sitta R; Cornelis F; Asselineau J; Aziza R; Daste A; Quemener C; Baud J; Bikfalvi A; Pedenon-Périchout D; Doussau A; Molimard M; Delord JP
    Eur J Cancer; 2017 Nov; 85():39-48. PubMed ID: 28886476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on the effects of chemotherapy as treatment of renal cell carcinoma].
    Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):43-9. PubMed ID: 3379331
    [No Abstract]   [Full Text] [Related]  

  • 12. New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.
    Isaacs WB; Isaacs JT; Kyprianou N; Burgers JK; Alexander RB; Partin AW; Mohler JL; Marshall FF; Coffey DS
    Eur Urol; 1990; 18 Suppl 2():33-5. PubMed ID: 2226604
    [No Abstract]   [Full Text] [Related]  

  • 13. Progressive anemia following combination therapy with interferon-alpha and interleukin-2 in a patient with metastatic renal cell carcinoma.
    Hosokawa Y; Kishino T; Ono T; Oyama N; Hayashi K; Momose H
    Int J Urol; 2004 Oct; 11(10):906-8. PubMed ID: 15479299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter phase II trial of combination therapy with meloxicam, a cox-2 inhibitor, and natural interferon-alpha for metastatic renal cell carcinoma.
    Shinohara N; Kumagai A; Kanagawa K; Maruyama S; Abe T; Sazawa A; Nonomura K
    Jpn J Clin Oncol; 2009 Nov; 39(11):720-6. PubMed ID: 19684042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase II study of bevacizumab and everolimus as treatment for refractory metastatic renal cell carcinoma.
    Harshman LC; Barbeau S; McMillian A; Srinivas S
    Clin Genitourin Cancer; 2013 Jun; 11(2):100-6. PubMed ID: 23352238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.
    Tourani JM; Pfister C; Berdah JF; Benhammouda A; Salze P; Monnier A; Paule B; Guillet P; Chretien Y; Brewer Y; Di Palma M; Untereiner M; Malaurie E; Tadrist Z; Pavlovitch JM; Hauteville D; Mejean A; Azagury M; Mayeur D; Lucas V; Krakowski I; Larregain-Fournier D; Abourachid H; Andrieu JM; Chastang C
    J Clin Oncol; 1998 Jul; 16(7):2505-13. PubMed ID: 9667271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
    Droz JP; Theodore C; Ghosn M; Lupera H; Piot G; De Forges A; Klink M; Rouesse J; Amiel JL
    Semin Surg Oncol; 1988; 4(2):97-9. PubMed ID: 3393780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinoma.
    Nathan PD; Gore ME; Eisen TG
    J Clin Oncol; 2002 Mar; 20(5):1429-30. PubMed ID: 11870194
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunochemotherapy of metastatic renal cell carcinoma: report of 28 cases.
    Wang HJ; Chen HX; Li HZ
    Chin Med J (Engl); 2005 Jan; 118(2):172-3. PubMed ID: 15667805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.